Abstract-Hypercholesterolemia is associated with impaired neovascularization in response to ischemia. Potential mechanisms include defective NO bioactivity and a reduction in the number/function of endothelial progenitor cells (EPCs). Here we tested the hypothesis that sildenafil, a phosphodiesterase 5 inhibitor that increases NO-driven cGMP levels, could stimulate EPC function and improve ischemia-induced neovascularization in hypercholesterolemic conditions. Apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice were treated (or not treated) with sildenafil (40 mg/kg per day in water), and hindlimb ischemia was surgically induced by femoral artery removal. Sildenafil treatment led to an improved blood flow recovery, an increased capillary density, and a reduction of oxidative stress levels in ischemic muscles at day 7 after surgery. Sildenafil therapy is associated with an increased activation of angiogenic transduction pathways, including Akt, p44/42 mitogen-activated protein kinase, and p38. In vitro, sildenafil increases cellular migration and tubule formation of mature endothelial cells (human umbilical vascular endothelial cells) in a cGMP-dependent manner. In vivo, ApoE Ϫ/Ϫ mice treated with sildenafil exhibit a significant increase in the number of bone marrow-derived EPCs. Moreover, the angiogenic activities of EPCs (migration and adhesion) are significantly improved in ApoE Ϫ/Ϫ mice treated with sildenafil. In summary, this study demonstrates that sildenafil treatment is associated with improved ischemia-induced neovascularization in hypercholesterolemic ApoE Ϫ/Ϫ mice. The mechanisms involve beneficial effects on angiogenic transduction pathways together with an increase in the number and the functional activity of EPCs. Sildenafil could constitute a novel therapeutic strategy to reduce tissue ischemia in atherosclerotic diseases. Key Words: sildenafil Ⅲ endothelial Ⅲ progenitor Ⅲ cells Ⅲ angiogenesis hypercholesterolemia T he ability of the organism to develop new blood vessels (neovascularization) constitutes an important adaptive response to vascular occlusive diseases. 1 Postnatal neovascularization necessitates the activation, migration, and proliferation of mature endothelial cells (angiogenesis). 2 In response to ischemia, hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF) have been shown to be critical limiting factors for the induction of angiogenesis. 3,4 The importance of NO for endothelial cell migration and VEGF-induced angiogenesis was also demonstrated recently. 5,6 However, increasing evidence suggests that postnatal neovascularization relies not exclusively on the sprouting of preexisting vessels, but also the contribution of bone marrowderived circulating endothelial progenitor cells (EPCs). 7 In young patients and in animal models with young and healthy animals, the neovascularization process is very effective so that blood flow restoration after ischemia is almost complete. Neovascularization, however, is impaired in several clinical situations, which leads to i...